MAPT and Alzheimer disease: Studies have demonstrated that in the pathological microenvironment of Alzheimer’s disease (AD), amyloid-beta (Aβ) deposition and abnormally phosphorylated Tau protein can induce the activation of microglia and astrocytes, which in turn secrete tumor necrosis factor-α (TNF-α).